Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks (Q42980879)
Jump to navigation
Jump to search
scientific article published on 14 August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks |
scientific article published on 14 August 2008 |
Statements
1 reference
Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks (English)
1 reference
Sugantha Govindarajan
1 reference
Maribel Rodriguez-Torres
1 reference
Moises Diago
1 reference
Thomas Morgan
1 reference
Bhupinderjit Anand
1 reference
Karl Barange
1 reference
Frank Suter
1 reference
Amy Lin
1 reference
Gregory Hooper
1 reference
Mitchell Shiffman
1 reference
14 August 2008
1 reference
1 reference
Identifiers
1 reference